CLINICAL_TRIALS
other
· 2026-02-20
Clinical Trial Update: A Study of ONO-1110 in Patients With Social Anxiety Disorder [Phase 2]
Summary
A Phase 2 clinical trial update for ONO-1110 in social anxiety disorder indicates the study is currently active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Social Anxiety Disorder (SAD) | Phase 2 | Status: ACTIVE_NOT_RECRUITING